News >

Shields Sheds Light on Complex mCRC Landscape

Brandon Scalea
Published: Thursday, May 16, 2019

Anthony Shields, MD, PhD

Anthony Shields, MD, PhD

Immunotherapy and targeted therapy have shown promise in the treatment of select subsets of patients with metastatic colorectal cancer (mCRC) who harbor genetic alterations, but the question of whether this benefit can be extended into a broader patient population remains unanswered, said Anthony Shields, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 22nd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and MyelomaMay 30, 20192.0
Online Medical Crossfire®: 5th Annual Miami Lung Cancer ConferenceMay 30, 20196.5
Publication Bottom Border
Border Publication